Skip to main content
TipRanks
Go Ultimate75% OFF

Fuso Pharmaceutical Industries,Ltd. (4538) Stock Statistics & Valuation Metrics

0 Followers

Total Valuation

Fuso Pharmaceutical Industries,Ltd. has a market cap or net worth of JPY 19.25B. The enterprise value is JPY 36.68B.

Market Cap
JPY 19.25B
Enterprise Value
JPY 36.68B

Share Statistics

Fuso Pharmaceutical Industries,Ltd. has 9,451,169 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
9,451,169
Owned by Insiders
―
Owned by Institutions
1.73%

Financial Efficiency

Fuso Pharmaceutical Industries,Ltd.’s return on equity (ROE) is 0.06 and return on invested capital (ROIC) is 3.34%.

Return on Equity (ROE)
0.06
Return on Assets (ROA)
0.02
Return on Invested Capital (ROIC)
3.34%
Return on Capital Employed (ROCE)
0.07
Revenue Per Employee
45.48M
Profits Per Employee
1.47M
Employee Count
1,370
Asset Turnover
0.69
Inventory Turnover
2.95

Valuation Ratios

The current PE Ratio of Fuso Pharmaceutical Industries,Ltd. is 8.33. Fuso Pharmaceutical Industries,Ltd.’s PEG ratio is 0.05.

PE Ratio
8.33
PS Ratio
0.29
PB Ratio
0.51
Price to FCF
0.00
Price to Operating Cash Flow
0.00
PEG Ratio
0.05

Income Statement

In the last 12 months, Fuso Pharmaceutical Industries,Ltd. had revenue of 62.31B and earned 2.01B in profits. Earnings per share was 235.52.

Revenue
62.31B
Gross Profit
15.99B
Operating Income
2.64B
Pretax Income
2.44B
Net Income
2.01B
EBITDA
5.38B
Earnings Per Share (EPS)
235.52

Cash Flow

In the last 12 months, operating cash flow was 0 and capital expenditures 0, giving a free cash flow of 0 billion.

Operating Cash Flow
0
Free Cash Flow
0
Free Cash Flow per Share
0.00

Dividends & Yields

Fuso Pharmaceutical Industries,Ltd. pays an annual dividend of JPY 45.00, resulting in a dividend yield of 4.10%

Dividend Per Share
JPY 45.00
Dividend Yield
4.10%
Payout Ratio
35.79%
Free Cash Flow Yield
0.00%
Earnings Yield
12.00%

Stock Price Statistics

Beta
0.51
52-Week Price Change
-0.05%
50-Day Moving Average
2152.45
200-Day Moving Average
2174.49
Relative Strength Index (RSI)
60.86
Average Volume (3m)
20.50K

Important Dates

Fuso Pharmaceutical Industries,Ltd. upcoming earnings date is Feb 11, 2027, TBA (Not Confirmed).

Last Earnings Date
Nov 11, 2026
Next Earnings Date
Feb 11, 2027
Ex-Dividend Date
Mar 30, 2026

Financial Position

Fuso Pharmaceutical Industries,Ltd. as a current ratio of 1.11, with Debt / Equity ratio of 81.19%

Current Ratio
1.11
Quick Ratio
0.81
Debt to Market Cap
1.41
Net Debt to EBITDA
4.39
Interest Coverage Ratio
8.05

Taxes

In the past 12 months, Fuso Pharmaceutical Industries,Ltd. has paid 426.00M in taxes.

Income Tax
426.00M
Effective Tax Rate
0.17

Enterprise Valuation

Fuso Pharmaceutical Industries,Ltd. EV to EBITDA ratio is 6.32, with an EV/FCF ratio of 0.00.

EV to Sales
0.57
EV to EBITDA
6.32
EV to Free Cash Flow
0.00
EV to Operating Cash Flow
0.00

Balance Sheet

Fuso Pharmaceutical Industries,Ltd. has JPY 4.57B in cash and marketable securities with JPY 26.31B in debt, giving a net cash position of -JPY 21.74B billion.

Cash & Marketable Securities
JPY 4.57B
Total Debt
JPY 26.31B
Net Cash
-JPY 21.74B
Net Cash Per Share
-JPY 2,299.93
Tangible Book Value Per Share
JPY 4,036.27

Margins

Gross margin is 25.40%, with operating margin of 4.94%, and net profit margin of 3.50%.

Gross Margin
25.40%
Operating Margin
4.94%
Pretax Margin
4.36%
Net Profit Margin
3.50%
EBITDA Margin
9.06%
EBIT Margin
5.14%

Analyst Forecast

The average price target for Fuso Pharmaceutical Industries,Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
―
Revenue Growth Forecast
2.29%
EPS Growth Forecast
―

Scores

Smart Score
―
AI Score
63